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Procedural sedation, also known as conscious sedation is used for minimally 
invasive procedures performed outside the operating room where pain or surgical 
stimulation is not great enough to require general anesthesia.  These cases include 
procedures such as catheter placement, endoscopy, certain plastic procedures, dental 
procedures, dermatological procedures and certain pulmonary procedures.   
These are procedures where sedation and a light analgesic effect are needed but 
anesthetic depth requiring intubation and mechanical ventilation is avoided.  
Unfortunately, these sedations are not typically attended to by a fully trained 
anesthesiologist so the caregiver administering the drug does not have a very intuitive 
feel for the anesthetic depth of their patient.  Accordingly, it is quite common for the 
caregiver to under dose leading to elevated heart rate and blood pressure or even regain 
of consciousness (which I myself experienced once when undergoing a dental implant 
procedure) or over dosing causing apnea.  In the latter case the caregiver has to call an 
anesthetist to bag ventilate or intubate and mechanically ventilate the patient until 
spontaneous breathing is regained.  Both situations are very undesirable.   
To help prevent such dosing errors, Dwayne Westenskow has developed a 
simulation system to predict the synergistic effect for Propofol (Prop), a sedative, and 
Remifentanil (Remi), an opioid, when administered together.  Remi and Prop are 
commonly administered together in varied amounts to get a desired sedation and pain 
relief in both general anesthesia as well as procedural sedation.  This simulator uses 
pharmacokinetic models to determine effect site concentration from the drug 
administrations, and then uses pharmacodynamic models to map these concentrations to a 
probabilistic drug effect surface.  The effect of Prop and Remi together are so highly non-
linear and synergistic that it’s easy to understand why caregivers less experienced with 
anesthetic drugs can easily over or under dose during procedural sedation.  However, 
with the simulator described above, a close estimate of drug effect site concentration and 
remi/prop synergy can by calculated from the dosing regimen and displayed graphically.  
This can provide the caregiver an idea of anesthetic depth, which is difficult to assess 
from simple observation.  Of greater value is the model’s ability to predict the future drug 
effect on-line so the caregiver can see what the anesthetic level will be over the next few 
minuets and take action before a critical event occurs. 
As a validation of this model, we obtained a data set for eight subjects undergoing 
procedural sedation wherein the investigator started the subject on a specified dosing 
regimen of remi and prop and requested the subject to squeeze a ball about every 16 
seconds.  The time required for the subject to respond by squeezing the ball was 
recorded.  We used the dosing regimen to model the effect site concentration of remi and 
prop at each data point and color-coded the data according to the response time.  We 
plotted the data on a two dimensional plot with remi and prop effect site concentrations 
as the x and y-axis.  The z-axis or third dimension of the plot is the population probability 
of response or no response to the selected stimulus surface.  We selected the algometry 
surface.  A population probability surface for algometry shows the probability of 
responding to the stimulus at a given effect site concentration of remi and prop for any 
member of the population.  Thus, the x-axis and y-axis show remi and prop 
concentrations and the z-axis is a scale from 0 to 1 or 0% to 100% indicating the 
probability of not responding to algometry.   
Figure 1 is an example graph for one of the eight data sets.  The two horizontal 
dark lines represent slices through the surface at 50% probability of non-response (EC50 
isobol) and 95% probability of non-response (EC95 isobol).  If a subject has an effect site 
concentrations of remi and prop that correspond to any point along the EC50 isobol, we 
expect the subject to have a 50% probability of responding to algometry.   
 
 
To make the figure printable in black and white, we replaced the color-coding of each 
data point with a simple solid black/open white scheme indicating response or non-
response.  Subjects that responded in less than 14 seconds by squeezing the ball were 
marked as responders.  In figure one we can fallow the course of anesthetic starting at 
0,0.  We can see that this subject received a bolus of Remi fallowed by an infusion of 
Prop after the Remi nears its peak effect.  Then the subject is maintained near the EC95 
with infusions and small boluses.  We can make two interesting observations from this 
data set.  First, a high probability of non-response is reached and maintained for more 
than a minute before loss of response is observed.  This can most likely be attributed to 
surgical stimulus.  A subject’s ability to respond to verbal or other types of stimulus is 
highly dependent on the stimulus caused by the procedure at that moment.  So a subject 
experiencing algometry in isolation would very likely not respond near the EC95.  But 
with the added stimulus of the procedure, some stimulus threshold is more easily crossed 
and the surface is less reliable.  The second interesting observation is that the subject does 
not start to respond again until the effect site concentration has almost reached zero 
probability of non-response or zero on the z-axis.  It would be a stretch to attribute such 
lack of responsiveness entirely to lack of surgical stimulus, indicating that hystereses of 
the drug effect causes a greatly shifted surface for return of response as compared to loss 
of response.  These two observations are seen in all eight data sets. 
This is a three-dimensional surface but typically it is given in a two dimensional 
graph with two curves corresponding to the EC50 and EC95.  This does not illustrate the 
complete shape of the surface but indicates roughly the probability of non-response.  
Figures 2 through 9 show the eight data sets in a two dimensional form.  Compare figure 
one with figure nine to see the difference in visualization between the two methods. 
Note the great variability in drug sensitivity among the eight subjects.  Some 
subjects are less sensitive, continuing to respond above the EC95 as in figure 3 or loosing 
response below the EC50 as in figure 6. 
 
 
 
 Despite variability, the model does predict effect site concentrations between the 
EC50 and EC95 when loss of response was observed for most of the eight subjects, thus 
the data presented would be valuable to the care giver if viewed during the procedure in 
real time as a means of estimation anesthetic depth.    To date, the simulator has the 
ability to indicate drug effect site concentration and the subject’s probability to 
responding to some stimulus.  We have become interested in adding another level of 
assessment by using end tidal CO2 and minute volume to predict and display an isobol 
line on the surface indicating the effect site concentrations of remi and prop which would 
result in the patient becoming apneic.  In other words, the model currently shows if the 
patient is sedated enough.  We hope to add the other boundary showing if the patient is 
too sedated for conscious sedation and likely to stop breathing. 
Creating a surface describing ventilation or minute volume as a function of the 
two drug concentrations is more complex and prone to error than the simple response to 
stimuli surfaces because ventilatory drive is so heavily dependent on arterial CO2, drug 
sensitivity and surgical stimulus.  As anesthesia is induced, ventilatory drive decreases 
leading to decreased minute ventilation.  This causes an elevation in arterial CO2.  The 
increased CO2 increases ventilatory drive so the patient continues breathing.  This cycle 
holds unless the induction of anesthesia is to rapid, and the CO2 can’t elevate fast enough 
or if anesthetic depth is sufficiently great such that elevated CO2 no longer affects 
ventilatory drive.  This interplay is further complicated because elevated CO2 causes 
elevated heart rate, carrying the drug to the effect site (the brain in our case) more quickly 
causing accelerated drug effects.  A population surface for ventilation would have to be 
determined for each level of arterial CO2.   
We are currently considering a more patient specific approach by measuring end 
tidal CO2 and minute volume both before drug is administered and during the procedure 
then fitting the rough ventilation surface reported in literature to the patients actual values 
to give a more accurate estimate of when apnea may occur.  This would be accomplished 
by applying a simple function reported in literature, which relates minute volume as a 
function of CO2 for subjects without sedatives.  This model would be shifted such that its 
predicted resting minute volume and CO2 match that of the subject.  The surface would 
be fit to pass through this point at the zero remi and prop conc. point on the 3-D surface.  
The second point that the surface would be forced to pass through would be the patients 
actual minute volume at the modeled concentration of remi and prop.  Thus the surface 
would be shifted and tilted to fit the subject’s actual minute volume in real time giving a 
more accurate prediction of the danger of apnea.  If this method proves successful, 
caregivers administering remi and prop in procedural sedation will be warned of a 
possible critical event before it happens and better determine the dosing necessary to 
maintain their patient at a safe level of sedation. 
